Tag:#Cannabis Capital Markets

As 2021 US-To-Europe Transactions Pass $600m Are We Witnessing A Second Transatlantic Wave?

IT’S still early days but after a faltering start by its North American neighbours US cannabis companies are now taking tentative steps into Europe. This...

‘With Legalisation Gathering Momentum We Are Witnessing The Emergence Of A Global Cannabis Industry’

NEW analysis from Prohibition Partners on the trajectory of the cannabis industry predicts significant global growth over the coming years  The 'The Global Cannabis Report:...

Hemp Pioneer On The $11.2m Sale Of His Business And The Decade’s ‘Most Exciting Industry’

EUROPEAN cannabis industry ‘pioneer’ Daniel Kruse believes that Germany is poised to ‘lead the way for a new global drug policy’.  With the incoming German...

London Stock Exchange Cannabis Company Values Down Almost £200m From Early Peaks

THIS has been a transformative year for the European cannabis industry, with growing liberalisation across the continent opening the floodgates for patients and investors...

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from the fallout of a...

Work To Start On UK Mainland’s First Commercial Cannabis Cultivation Facility For Over 20 Years

GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over 20 years.  The deal will...

MGC Pharmaceuticals Tells Shareholders Pending Deal Could ‘Transform Finances Overnight’

MGC Pharmaceuticals told shareholders attending its Annual General Meeting (AGM) that it is on track to deliver ‘far and away the best financial performance...

SynBiotic SE Buys Hemp Pioneer’s Group Of Companies For €11.2m

It is the most significant merger in the European cannabis sector. SynBiotic SE has acquired 50.1% of Daniel Kruse’s group of companies, with four...

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...
- Advertisement -spot_imgspot_img

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read